EpiEndo Pharmaceuticals ehf, 102 Reykjavik, Iceland.
Phialogics AG, Basel, Switzerland.
Inflammopharmacology. 2024 Aug;32(4):2253-2283. doi: 10.1007/s10787-024-01500-4. Epub 2024 Jun 15.
This article is an autobiographical account of a research career in inflammatory diseases, mechanisms and pharmacotherapy, drug research and development, in academia and industry in various European countries spanning the last 55 years. The author describes how tenacity and independent thought, learned in formative years, and tempered later by the development of good relationships with colleagues have guided his career. This has spanned research, among other fields, on prostaglandins as pro-and anti-inflammatory mediators, oxidative stress and antioxidants, phospholipid mediators, cytokines, innate and adaptive immune responses and the establishment of various inflammatory and immunological models. The author has helped discover and develop novel therapeutic approaches to pain, arthritic, dermatological, respiratory, and autoimmune disorders and contributed to bringing eight drug candidates to clinical trials. He has helped establish new research labs in four different centres and been involved in teaching undergraduate and mature students in three different universities. With extensive experience in scientific publishing and several international awards, he emphasises that without good teamwork, little can be achieved in scientific research.
本文是一篇自传体文章,讲述了作者在过去 55 年中,在炎症性疾病、机制和药物治疗学、药物研究和开发领域,在欧洲多个国家的学术界和工业界从事研究工作的经历。作者描述了坚韧不拔和独立思考的精神,这些精神在成长过程中形成,并在后来与同事建立良好关系的过程中得到锤炼,指导了他的职业生涯。这涵盖了在前列腺素作为促炎和抗炎介质、氧化应激和抗氧化剂、磷脂介质、细胞因子、先天和适应性免疫反应以及建立各种炎症和免疫模型等领域的研究。作者帮助发现和开发了治疗疼痛、关节炎、皮肤病、呼吸系统和自身免疫性疾病的新疗法,并为 8 种候选药物进入临床试验做出了贡献。他帮助在四个不同的中心建立了新的研究实验室,并在三所不同的大学教授本科和成熟学生。作者在科学出版方面拥有丰富的经验,并获得了多个国际奖项,他强调,没有良好的团队合作,在科学研究中几乎一事无成。